E-ISSN: 1308-5263
Turk J Hematol. Ahead of Print: TJH-76032 | DOI: 10.4274/tjh.galenos.2025.2025.0216
2University of Kansas Medical Centre, Plasma Cell Disorder Program, Division of Hematologic Malignancies & Cellular Therapeutics, Kansas, USA
3PD Hinduja National Hospital and Medical Research Centre, Department of Medical Oncology and Cellular Therapy, Mumbai, India
4Tata Memorial Centre, Department of Hematopathology, ACTREC, Navi Mumbai, India
5Speciality Surgical Oncology Hospital, Department of Oncosurgery, Ghatkopar, India
6YB Chavan College of Pharmacy, Department of Pharmaceutics, Aurangabad, India
Keywords: Multiple Myeloma, Secondary Plasma cell Leukemia, BCMA CAR T, Teclistamab
Defying the Odds: Successful Rescue with Teclistamab in a Case of Ultra- High-Risk Relapsed/Refractory Multiple Myeloma Transforming to Secondary Plasma Cell Leukemia Post-BCMA CAR T Failure
Bilal Kazi1, Al-ola Adallah2, Vijay Patil3, Prashant Tembhare4, Imaan Rumani5, Marzooka Nazim Chishti Kazi61PD Hinduja National Hospital and Medical Research Centre, Department of Hematology, Bone Marrow Transplantation and Cellular Therapy, Mumbai, India2University of Kansas Medical Centre, Plasma Cell Disorder Program, Division of Hematologic Malignancies & Cellular Therapeutics, Kansas, USA
3PD Hinduja National Hospital and Medical Research Centre, Department of Medical Oncology and Cellular Therapy, Mumbai, India
4Tata Memorial Centre, Department of Hematopathology, ACTREC, Navi Mumbai, India
5Speciality Surgical Oncology Hospital, Department of Oncosurgery, Ghatkopar, India
6YB Chavan College of Pharmacy, Department of Pharmaceutics, Aurangabad, India
Keywords: Multiple Myeloma, Secondary Plasma cell Leukemia, BCMA CAR T, Teclistamab
Corresponding Author: Bilal Kazi
Manuscript Language: English
Manuscript Language: English
Copyright © 2025 Turkish Journal of Hematology